Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
5.71
+0.65 (12.85%)
At close: Nov 7, 2025, 4:00 PM EST
5.58
-0.13 (-2.28%)
After-hours: Nov 7, 2025, 7:32 PM EST
Alvotech Market Cap
Alvotech has a market cap or net worth of $1.79 billion as of November 7, 2025. Its market cap has decreased by -54.07% in one year.
Market Cap
1.79B
Enterprise Value
2.90B
1-Year Change
-54.07%
Ranking
Category
Stock Price
$5.71
Market Cap Chart
Since November 9, 2020, Alvotech's market cap has increased from $304.69M to $1.79B, an increase of 486.61%. That is a compound annual growth rate of 42.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 1.79B | -55.21% |
| Dec 31, 2024 | 3.99B | 30.92% |
| Dec 29, 2023 | 3.05B | 22.59% |
| Dec 30, 2022 | 2.49B | 705.34% |
| Dec 31, 2021 | 308.75M | -5.82% |
| Dec 31, 2020 | 327.81M | 7.59% |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Abbott Laboratories | 219.72B |
| Thermo Fisher Scientific | 215.06B |